| Application no. and date | 18745741.1 (espacenet) (Federated) (European Patent Register), 20180629 | | Patent/reg. no. and date | DK/EP 3775165, 20240327 | | Publication date | 20210217 | | Priority no. and date | US 201815940901, 20180329 | | EP pub. no. and date |
EP 3775165 20210217 | | Effective date | | | Applicant/owner | Iovance Biotherapeutics, Inc., 825 Industrial Road
Suite 400
San Carlos, CA 94070, US | | Applicant ref. no. | V2406-017-DK | | Inventor | BENDER, James, 3 Cloverdale
Rancho Santa Margarita, CA 92688, US,
WARDELL, Seth, c/o Iovance Biotherapeutics, Inc.
999 Skyway Road
Suite 150
San Carlos
CA 94070, US | | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | | Opponent | | | IPC Class | A01N 1/02 (2006.01) , A61K 35/17 (2015.01) , C12M 3/00 (2006.01) , C12N 5/0783 (2010.01) | | Title | FREMGANGSMÅDER TIL FREMBRINGELSE AF TUMORINFILTRERENDE LYMFOCYTTER OG ANVENDELSER HERAF I IMMUNTERAPI | | Int. application no. | US2018040474 | | Int. publication no. | WO2019190579 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
